InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
4
Disclosed sells
0
T+90 hit rate
43%
T+90 mean return
0.0%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by VALERIANI NICHOLAS J, Director. Director active across 2 companies, notably Edwards Lifesciences Corp. Cumulatively, 15 disclosures have been recorded. Breakdown: 4 buys · 0 sell. Total volume traded: €388k. History available since 5 May 2021. The latest transaction was disclosed on 9 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations15 total
5,564 shares0Common StockSEC:0001225208-25-004956:0
4,818 shares0Common StockSEC:0001225208-24-005897:0
2,803 shares0Common StockSEC:0001225208-23-005911:0
22,857 shares0Common StockSEC:0001209191-22-046170:0
2,300 shares0Common StockSEC:0001225208-22-006588:0
1,500 shares@ US$112.230.0003% mcap50.0% of flowCommon StockSEC:0001225208-21-014149:0
Canonical exit: 22 Feb 2022 (T+90)
1,500 shares@ US$112.230.0003% mcap100.0% of flowCommon StockSEC:0001225208-21-014149
Canonical exit: 22 Feb 2022 (T+90)
55,000 shares@ US$0.9550.0% of flowCommon StockSEC:0001209191-21-051328
Canonical exit: 10 Nov 2021 (T+90)
55,000 shares@ US$0.9550.0% of flowCommon StockSEC:0001209191-21-051328:0
Canonical exit: 10 Nov 2021 (T+90)
72,254 shares0Common StockSEC:0001209191-21-045041:0
72,254 shares0Common StockSEC:0001209191-21-045041
57,803 shares0Common StockSEC:0001209191-21-031342
57,803 shares0Common StockSEC:0001209191-21-031342:0
2,615 shares0Common StockSEC:0001225208-21-007760
2,615 shares0Common StockSEC:0001225208-21-007760:0
15 of 15 declarations
About VALERIANI NICHOLAS J
Nicholas J. Valeriani is a Board Member at Edwards Lifesciences Corp and Surgalign Holdings, Inc. In this role, he contributes to the governance of these companies, bringing his expertise to the board. Edwards Lifesciences is a leader in medical technologies, while Surgalign focuses on surgical solutions. Mr. Valeriani's experience in these sectors is valuable for guiding strategic decisions.
